RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 82 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,960,814 | +49.3% | 1,045,057 | +7.4% | 0.00% | +50.0% |
| Q2 2023 | $16,050,546 | +90.3% | 973,350 | +105.9% | 0.00% | +100.0% |
| Q1 2023 | $8,434,062 | +63071.8% | 472,761 | +3.1% | 0.00% | -50.0% |
| Q4 2022 | $13,351 | -99.9% | 458,510 | +18.1% | 0.00% | +100.0% |
| Q3 2022 | $9,508,000 | +473.1% | 388,112 | -2.9% | 0.00% | – |
| Q2 2022 | $1,659,000 | -80.6% | 399,794 | -46.0% | 0.00% | -100.0% |
| Q1 2022 | $8,535,000 | +19.8% | 740,889 | +3.8% | 0.00% | 0.0% |
| Q4 2021 | $7,125,000 | -18.3% | 714,028 | +6.9% | 0.00% | 0.0% |
| Q3 2021 | $8,719,000 | -35.0% | 667,658 | -2.5% | 0.00% | -50.0% |
| Q2 2021 | $13,410,000 | +1.1% | 684,903 | +9.8% | 0.00% | 0.0% |
| Q1 2021 | $13,263,000 | -8.7% | 623,562 | +27.7% | 0.00% | 0.0% |
| Q4 2020 | $14,521,000 | +36.3% | 488,447 | -0.7% | 0.00% | 0.0% |
| Q3 2020 | $10,654,000 | +0.2% | 491,679 | +3.1% | 0.00% | 0.0% |
| Q2 2020 | $10,631,000 | +57.6% | 476,750 | +7.6% | 0.00% | 0.0% |
| Q1 2020 | $6,746,000 | -63.1% | 443,257 | -44.3% | 0.00% | 0.0% |
| Q4 2019 | $18,270,000 | +166.8% | 795,750 | +150.8% | 0.00% | 0.0% |
| Q3 2019 | $6,849,000 | -0.4% | 317,273 | +1.5% | 0.00% | 0.0% |
| Q2 2019 | $6,875,000 | -0.5% | 312,536 | +24.0% | 0.00% | 0.0% |
| Q1 2019 | $6,907,000 | -45.1% | 252,017 | -46.1% | 0.00% | 0.0% |
| Q4 2018 | $12,574,000 | +140.0% | 467,788 | +160.4% | 0.00% | +100.0% |
| Q3 2018 | $5,240,000 | +84.6% | 179,647 | +97.8% | 0.00% | 0.0% |
| Q2 2018 | $2,839,000 | +19.5% | 90,828 | -23.9% | 0.00% | 0.0% |
| Q1 2018 | $2,375,000 | -34.0% | 119,358 | -3.6% | 0.00% | 0.0% |
| Q4 2017 | $3,597,000 | – | 123,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |